Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2026061003;61004;61005 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
N2AB1861956080;56081;56082 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
N2A1769253299;53300;53301 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
N2B1119533808;33809;33810 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
Novex-11132034183;34184;34185 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
Novex-21138734384;34385;34386 chr2:178590947;178590946;178590945chr2:179455674;179455673;179455672
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Fn3-34
  • Domain position: 90
  • Structural Position: 123
  • Q(SASA): 0.2635
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/F None None 0.999 D 0.9 0.385 0.761728025676 gnomAD-4.0.0 1.59225E-06 None None None None N None 0 0 None 0 0 None 0 0 2.8603E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.3321 likely_benign 0.4084 ambiguous -0.598 Destabilizing 0.994 D 0.522 neutral D 0.524375772 None None N
S/C 0.3047 likely_benign 0.3718 ambiguous -0.28 Destabilizing 1.0 D 0.843 deleterious D 0.528948277 None None N
S/D 0.9571 likely_pathogenic 0.9659 pathogenic 0.071 Stabilizing 0.998 D 0.797 deleterious None None None None N
S/E 0.9868 likely_pathogenic 0.9911 pathogenic 0.167 Stabilizing 0.998 D 0.789 deleterious None None None None N
S/F 0.9179 likely_pathogenic 0.9595 pathogenic -0.613 Destabilizing 0.999 D 0.9 deleterious D 0.528694787 None None N
S/G 0.3709 ambiguous 0.4573 ambiguous -0.933 Destabilizing 0.998 D 0.677 prob.neutral None None None None N
S/H 0.9362 likely_pathogenic 0.9526 pathogenic -1.253 Destabilizing 1.0 D 0.848 deleterious None None None None N
S/I 0.8556 likely_pathogenic 0.914 pathogenic 0.211 Stabilizing 0.999 D 0.855 deleterious None None None None N
S/K 0.9964 likely_pathogenic 0.9975 pathogenic -0.121 Destabilizing 0.998 D 0.786 deleterious None None None None N
S/L 0.6664 likely_pathogenic 0.7818 pathogenic 0.211 Stabilizing 0.999 D 0.799 deleterious None None None None N
S/M 0.7797 likely_pathogenic 0.829 pathogenic 0.183 Stabilizing 1.0 D 0.847 deleterious None None None None N
S/N 0.8549 likely_pathogenic 0.8926 pathogenic -0.399 Destabilizing 0.998 D 0.789 deleterious None None None None N
S/P 0.9778 likely_pathogenic 0.9919 pathogenic -0.022 Destabilizing 0.999 D 0.85 deleterious D 0.525415922 None None N
S/Q 0.9792 likely_pathogenic 0.9832 pathogenic -0.304 Destabilizing 0.999 D 0.857 deleterious None None None None N
S/R 0.9929 likely_pathogenic 0.9958 pathogenic -0.325 Destabilizing 0.999 D 0.848 deleterious None None None None N
S/T 0.2588 likely_benign 0.2897 benign -0.33 Destabilizing 0.997 D 0.704 prob.delet. N 0.469330566 None None N
S/V 0.7819 likely_pathogenic 0.8534 pathogenic -0.022 Destabilizing 0.999 D 0.853 deleterious None None None None N
S/W 0.9499 likely_pathogenic 0.9751 pathogenic -0.686 Destabilizing 1.0 D 0.902 deleterious None None None None N
S/Y 0.9114 likely_pathogenic 0.9545 pathogenic -0.308 Destabilizing 0.999 D 0.913 deleterious D 0.528441298 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.